2007 -2010 President and Chief Executive Officer @ Allegro Diagnostics
2003 -2006 Senior Director, Business Development @
2001 -2003 Chief Executive Officer @ Macrocyclics
1998 -2001 Associate Director Business Development @
Daniel Rippy Education
Massachusetts Institute of Technology
Master of Science (Health Science)
2006-2007
Columbia University
Master of Business Administration
1991-1993
Macalester College
Bachelor of Arts (Political Science, Spanish)
1985-1989
Daniel Rippy Skills
Pharmaceutical Industry
Strategic Planning
Medical Devices
Lifesciences
Start-ups
Business Strategy
Biotechnology
Corporate Development
Commercialization
Strategic Partnerships
Mergers
Analytics
Business Development
Biopharmaceuticals
Business Planning
Clinical Trials
Cardiology
Clinical Development
Clinical Research
Competitive Analysis
Competitive Intelligence
Cross-functional Team Leadership
Dermatology
Drug Development
Due Diligence
Executive Management
FDA
Financial Modeling
Finance
Hardware Diagnostics
Healthcare
Health Economics
Global Marketing
Entrepreneurship
Capital Equipment
Infectious Diseases
Intellectual Property
International Business
Licensing
Management
Management Consulting
Market Analysis
Market Research
Mergers & Acquisitions
Marketing Strategy
Market Development
Market Planning
Marketing
Marketing Management
Molecular Biology
Start Ups
Cross Functional Team Leadership
Mergers and Acquisitions
Daniel Rippy Summary
Daniel Rippy, based in Boston, MA, US, is currently a Executive Director Business Development at UMass Chan Medical School. Daniel Rippy brings experience from previous roles at Liquiglide, Lantheus Medical Imaging and Macalester College. Daniel Rippy holds a 2006 - 2007 Master of Science in Health Science @ Massachusetts Institute of Technology. With a robust skill set that includes Pharmaceutical Industry, Strategic Planning, Medical Devices, Lifesciences, Start-ups and more. Daniel Rippy has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Daniel Rippy?
Find contact details for 700 million professionals.